Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2025 Earnings Call Transcript May 6, 2025
Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-1.57 EPS, expectations were $-1.54.
Operator: Good afternoon, and welcome to the Ultragenyx First Quarter 2025 Financial Results Conference call. At this time, all participants are in a listen-only mode. At the end of the prepared remarks, you will have an opportunity to ask questions during the Q&A portion of the call. It...
